HomeProductsBuilding BlocksHeterocyclic ScaffoldsPyrrolesOsilodrostat
Chemical structure of CAS 928134-65-0

Osilodrostat

CAS No.928134-65-0
MDL No.N/A
MFC13H10FN3
MW227.24
InChI KeyUSUZGMWDZDXMDG-CYBMUJFWSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.928134-65-0
Product NameOsilodrostat

Biological Targets

CYP11B1

Associated Conditions

kidney disease·hypertension·adrenal gland disease·Primary hyperaldosteronism·pituitary-dependent Cushing's disease·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Osilodrostat: First Approval.

Drugs • Vol. 80, Issue 5 • 2020
PMID: 32141023DOI: 10.1007/s40265-020-01277-0

Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing's syndrome.

European journal of endocrinology • Vol. 172, Issue 6 • 2015
PMID: 25637072DOI: 10.1530/EJE-14-1014

Medical treatment of Cushing disease: new targets, new hope.

Endocrinology and metabolism clinics of North America • Vol. 44, Issue 1 • 2015
PMID: 25732642DOI: 10.1016/j.ecl.2014.10.006

Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers.

Pituitary • Vol. 18, Issue 2 • 2015
PMID: 25560275DOI: 10.1007/s11102-014-0627-0

Documentation

Similar Products